相关实验视频

Updated: Jun 13, 2025

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

冬眠器中的可逆冷诱导透镜不透明性揭示了治疗白内障的分子标

Hao Yang¹, Xiyuan Ping^1,2, Jiayue Zhou³

¹Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

The Journal of clinical investigation

|September 17, 2024

概括

冬眠的动物在寒冷压力期间保持蛋白质平衡. 研究人员发现,RNF114蛋白质复合物有助于防止蛋白质聚合,为治疗白内障提供了一种新的策略.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
生物化学生物化学

背景情况:

蛋白质平衡对于细胞功能和预防疾病至关重要.
白内障与蛋白质静止和蛋白质聚合的破坏有关.
冬眠者对寒冷压力表现出了显著的适应性,但它们的蛋白质稳定机制尚不清楚.

研究的目的:

调查冬眠地松鼠中可逆透镜不透明的基础分子机制.
确定在冷应力期间在透镜中防止蛋白质聚合物的积累的关键因素.
探索已确定治疗白内障的机制的治疗潜力.

主要方法:

建立了来自地松鼠的诱导多能干细胞,以创建透镜上皮细胞.
研究了无素-蛋白酶体系统 (UPS) 在控制透镜蛋白聚合,特别是αA-晶体素 (CRYAA) 的作用.
鉴定和表征了E3泛素结合酶RNF114.4.
设计了一个RNF114复合体,并在白内障的动物模型中测试了它的有效性.

主要成果:

地松鼠在冬眠重新升温期间表现出可逆透镜不透明现型.
这种UPS,特别是E3泛素结合酶RNF114,对于防止GS镜头中的CRYAA聚合至关重要.
RNF114在透镜蛋白循环和恒温中发挥着关键作用.
在老鼠和斑马鱼白内障模型中,使用RNF114复合物减少了透镜的不透明度.

结论:

在寒冷压力下,UPS对于维持蛋白质静止至关重要.
RNF114是一种新型的E3泛基因酶,参与CRYAA稳态并防止透镜蛋白聚合.
RNF114代表了与蛋白质聚合物相关的白内障的有前途的治疗标.

关键词:

眼科医生眼科眼科干细胞是一种干细胞.乌比奎丁-蛋白质组系统

更多相关视频

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application

Published on: March 8, 2019

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract

Published on: November 28, 2012

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...